Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 3/5/20181 min de lectura
Assessing User Fees Under the Prescription Drug User Fee Amendments of 2017; Guidance for Industry; Availability
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Assessing User Fees Under the Prescription Drug User Fee Amendments of 2017." This guidance concerns FDA's implementation of the Prescription Drug User Fee Amendments of 2017 (PDUFA VI) and certain changes in policies and procedures surrounding its application.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →